目的 内源性硫化氢(H2S) 作为心血管调节的新型气体信号分子,在动脉粥样硬化(AS)发生发展中发挥重要保护作用。本研究拟探讨H2S 供体对AS 大鼠肾上腺髓质素(ADM)和心钠素(ANP)的影响。方法 雄性SD 大鼠随机分为对照组、AS 组和AS+NaHS 组。AS 组和AS+NaHS 组大鼠给予连续3 d 腹腔注射维生素D3 及高脂饲料连续喂养8 周。AS+NaHS 组大鼠腹腔注射H2S 供体NaHS。油红O 染色法观察大鼠主动脉根部及冠状动脉斑块面积变化;敏感硫电极法测量血浆H2S 含量;放射免疫法检测血浆ADM 及ANP 含量。结果 与对照组相比,AS 大鼠主动脉根部及冠状动脉可见明显AS 斑块形成,血浆H2S 含量明显降低,ADM 含量升高,ANP 含量明显降低(P<0.01)。给予NaHS 干预8 周后,AS 大鼠的上述改变被逆转,表现为AS+NaHS组大鼠主动脉根部和冠状动脉AS 斑块面积明显缩小,血浆H2S 含量明显升高,ADM 含量明显降低,ANP 含量显著升高(P<0.01)。结论 H2S 对AS 大鼠血管活性多肽ADM、ANP 具有重要的调节作用。
Abstract
Objective Endogenous hydrogen sulfide (H2S), a novel gasotransmitter in cardiovascular regulation, plays an important protective role in the development and progression of atherosclerosis (AS). This study was designed to explore the effects of H2S donor on the production of adrenomedullin (ADM) and atrial natriuretic peptide (ANP) in AS rats. Methods Male Sprague-Dawley rats were randomly divided into control group (n=10), AS group (n=10), and AS+NaHS group (n=10). Rats in the AS and AS+NaHS groups were given 3-day intraperitoneal injections of vitamin D3 and 8-week high-fat diet to induce AS, and the rats in the AS+NaHS group were intraperitoneally injected with H2S donor NaHS. Oil red O staining was applied to detect changes in the areas of the atherosclerotic plaques in the aortic root and the coronary artery;sulfide-sensitive electrode method was used to measure the plasma concentration of H2S. ADM and ANP levels in plasma were determined by radioimmunoassay. Results Compared with the control group, marked atherosclerotic plaques were observed in the aortic root and the coronary artery in AS rats. Moreover, plasma H2S level decreased significantly, ADM level increased, and ANP level decreased significantly in AS rats (P<0.01). However, after the treatment with H2S donor NaHS for 8 weeks, the above changes in AS rats were reversed, demonstrated by significantly reduced areas of the atherosclerotic plaques in both the aortic root and the coronary artery, significantly increased plasma H2S level, significantly decreased plasma ADM level, and significantly increased plasma ANP level (P<0.01). Conclusions H2S plays an important regulatory effect on vasoactive peptides ADM and ANP in AS rats.
关键词
硫化氢 /
动脉粥样硬化 /
肾上腺髓质素 /
心钠素 /
大鼠
Key words
Hydrogen sulfide /
Atherosclerosis /
Adrenomedullin /
Atrial natriuretic peptide /
Rats
{{custom_sec.title}}
{{custom_sec.title}}
{{custom_sec.content}}
参考文献
[1] Herouvi D, Karanasios E, Karayianni C, et al. Cardiovascular disease in childhood:the role of obesity[J]. Eur J Pediatr, 2013, 172(6):721-732.
[2] Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults[J]. N Engl J Med, 1998, 338(23):1650-1656.
[3] Yu XH, Cui LB, Wu K, et al. Hydrogen sulfide as a potent cardiovascular protective agent[J]. Clin Chim Acta, 2014, 437:78-87.
[4] 王新宝, 金红芳, 杜军保. 新型气体信号分子硫化氢在心血管疾病中的意义[J]. 中国当代儿科杂志, 2009, 11(9):790-793.
[5] Wang Y, Zhao X, Jin H, et al. Role of hydrogen sulfide in the development of atherosclerotic lesions in apolipoprotein E knockout mice[J]. Arterioscler Thromb Vasc Biol, 2009, 29(2):173-179.
[6] Mani S, Untereiner A, Wu L, et al. Hydrogen sulfide and the pathogenesis of atherosclerosis[J]. Antioxid Redox Signal, 2014, 20(5):805-817.
[7] Qiao W, Chaoshu T, Hongfang J, et al. Endogenous hydrogen sulfide is involved in the pathogenesis of atherosclerosis[J]. Biochem Biophys Res Commun, 2010, 396(2):182-186.
[8] Xu S, Liu Z, Liu P. Targeting hydrogen sulfide as a promising therapeutic strategy for atherosclerosis[J]. Int J Cardiol, 2014,172(2):313-317.
[9] Lynn EG, Austin RC. Hydrogen sulfide in the pathogenesis of atherosclerosis and its therapeutic potential[J]. Expert Rev Clin Pharmacol, 2011, 4(1):97-108.
[10] Huang ZY, Yang PY, Almofti MR, et al. Comparative analysis of the proteome of left ventricular heart of arteriosclerosis in rat[J]. Life Sci, 2004, 75(26):3103-3115.
[11] Peh MT, Anwar AB, Ng DS, et al. Effect of feeding a high fat diet on hydrogen sulfide (H2S) metabolism in the mouse[J]. Nitric Oxide, 2014, 41:138-145.
[12] Mani S, Li H, Untereiner A, et al. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis[J]. Circulation, 2013, 127(25):2523-2534.
[13] Cheung SH, Kwok WK, To KF, et al. Anti-atherogenic effect of hydrogen sulfide by over-expression of cystathionine gammalyase (CSE) gene[J]. PLoS One, 2014, 9(11):e113038.
[14] Liu Z, Han Y, Li L, et al. The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E-/-mice[J]. Br J Pharmacol, 2013, 169(8):1795-1809.
[15] 刘颖, 米杰, 丁亚光, 等. 北京地区部分儿童血脂现状调查及气体分子硫化氢在血脂紊乱中的变化[J]. 北京大学学报 ( 医学版), 2006, 38(2):146-150.
[16] Peter EA, Shen X, Shah SH, et al. Plasma free H2S levels are elevated in patients with cardiovascular disease[J]. J Am Heart Assoc, 2013, 2(5):e000387.
[17] Altaany Z, Moccia F, Munaron L, et al. Hydrogen sulfide and endothelial dysfunction:relationship with nitric oxide[J]. Curr Med Chem, 2014, 21(32):3646-3661.
[18] Baskar R, Sparatore A, Del Soldato P, et al. Effect of S-diclofenac, a novel hydrogen sulfide releasing derivative inhibit rat vascular smooth muscle cell proliferation[J]. Eur J Pharmacol, 2008, 594(1-3):1-8.
[19] Wang XH, Wang F, You SJ, et al. Dysregulation of cystathionine γ-lyase (CSE)/hydrogen sulfide pathway contributes to ox-LDLinduced inflammation in macrophage[J]. Cell Signal, 2013, 25(11):2255-2262.
[20] Wen YD, Wang H, Kho SH, et al. Hydrogen sulfide protects HUVECs against hydrogen peroxide induced mitochondrial dysfunction and oxidative stress[J]. PLoS One, 2013, 8(2):e53147.
[21] Watanabe T, Sato K, Itoh F, et al. Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases[J]. Curr Protein Pept Sci, 2013, 14(6):472-480.
[22] Pan CS, Zhang J, Yu F, et al. Adrenomedullin ameliorates the development of atherosclerosis in apoE-/-mice[J]. Peptides, 2010, 31(6):1150-1158.
[23] Nakayama M, Takahashi K, Murakami O, et al. Adrenomedullin in monocytes and macrophages:possible involvement of macrophage-derived adrenomedullin in atherogenesis[J]. Clin Sci (Lond), 1999, 97(2):247-251.
[24] Gottsäter M, Ford LB, Ostling G, et al. Adrenomedullin is a marker of carotid plaques and intima-media thickness as well as brachial pulse pressure[J]. J Hypertens, 2013, 31(10):1959-1965.
[25] De Vito P. Atrial natriuretic peptide:an old hormone or a new cytokine[J]? Peptides, 2014, 58:108-116.
[26] Ichiki T1, Izumi R, Cataliotti A, et al. Endothelial permeability in vitro and in vivo:protective actions of ANP and omapatrilat in experimentalatherosclerosis[J]. Peptides, 2013, 48:21-26.
[27] Larifla L, Déprez I, Pham I, et al. Inhibition of vascular smooth muscle cell proliferation and migration in vitro and neointimal hyperplasia in vivo by adenoviral-mediated atrial natriuretic peptide delivery[J]. J Gene Med, 2012, 14(7):459-467.
[28] Gao P, Huang L. New insights into the role of natriuretic peptides in the regulation of apoptosis in cardiovascular system[J]. Saudi Med J, 2009, 30(5):595-604.
[29] De Vito P, Incerpi S, Pedersen JZ, et al. Atrial natriuretic peptide and oxidative stress[J]. Peptides, 2010, 31(7):1412-1419.
基金
国家自然科学基金重点项目(31130030);北京市自然科学基金(7121014);教育部博士学科点专项科研基金(20130001120047)。
PDF(1926 KB)
